Shares of Aquestive Therapeutics, Inc. (AQST) are up 21.15% in pre-market trading on Monday, following FDA approval of its drug Exservan for the treatment of neurological disorder amyotrophic lateral sclerosis (ALS).
from RTT - Biotech https://ift.tt/35pnVz4
via IFTTT
No comments:
Post a Comment